EX-23.1 3 rapt-ex23_1.htm EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

(1)
Registration Statement (Form S-8 No. 333-234448) pertaining to the 2015 Stock Plan, the 2019 Equity Incentive Plan and the 2019 Employee Stock Purchase Plan of RAPT Therapeutics, Inc.,
(2)
Registration Statements (Form S-8 Nos. 333-237487 and 333-270523) pertaining to the 2019 Equity Incentive Plan of RAPT Therapeutics, Inc.,
(3)
Registration Statements (Form S-8 Nos. 333-254127, 333-263426 and 333-277736) pertaining to the 2019 Equity Incentive Plan and the 2019 Employee Stock Purchase Plan of RAPT Therapeutics, Inc.; and
(4)
Registration Statements (Form S-3 Nos. 333-265812, 333-273910 and 333-284388) of RAPT Therapeutics, Inc.

of our report dated March 6, 2025, with respect to the financial statements of RAPT Therapeutics, Inc. included in this Annual Report (Form 10-K) of RAPT Therapeutics, Inc. for the year ended December 31, 2024.

/s/ Ernst & Young LLP

San Mateo, California

March 6, 2025